All-optical Quantitative Framework for Bioluminescence Tomography with Non-contact Measurement

In this contribution, we present an all-optical quantitative framework for bioluminescence tomography with non-contact measurement. The framework is comprised of four indispensable steps： extraction of the geometrical structures of the subject, light flux reconstruction on arbitrary surface, calibration and quantification of the surface light flux and internal bioluminescence reconstruction. In particular, the geometrical structures are retrieved using a completely optical method and captured under identical viewing conditions with the bioluminescent images. As a result, the proposed framework avoids the utilization of computed tomography or magnetic resonance imaging to provide the geometrical structures. On the basis of experimental measurements, we evaluate the performance of the proposed all-optical quantitative framework using a mouse shaped phantom. Preliminary result reveals the potential and feasibility of the proposed framework for bioluminescence tomography.

基于连接酶链式反应的EML4-ALK融合基因分型检测

针对棘皮动物微管相关蛋白样4-间变性淋巴瘤激酶(EML4-ALK)融合基因变异体V1、V2、V3a、V3b设计引物、探针,优化连接探针长度及其浓度,建立基于连接酶链式反应的qPCR法检测方案,并对该方案的特异性、检出限、抗干扰性进行验证。结果表明:基于连接酶链式反应的qPCR法能对EML4-ALK融合基因进行有效分型;连接探针长度在30 nt(nucleotide)时检测灵敏度、特异性最高;连接探针终浓度在0.1~1.0 nmol/L较为合适;设计的引物、探针特异性好,只扩增靶RNA,对其他RNA无扩增;对EML4-ALK融合基因变异体V1、V2的检出限为10 copies/μL,变异体V3a、V3b的检出限为100 copies/μL;在EML4-ALK融合基因RNA标准品检测过程中加入100 ng的肺癌样本RNA作为干扰,检测结果未受到明显干扰。

Effects of neoadjuvant chemotherapy on the quantitative expression of P-gp, LRP, MRP, GST-π in NSCLC and its clinical significance

Background and objective Neoadjuvant chemotherapy (NACT) plays an important role in systemic chemotherapy for non-small cell lung cancer (NSCLC). P-glycoprotein (P-gp), lung resistance related protein (LRP), multidrug resistance-associated protein (MRP) and glutathione S-transferase (GST-π) may be associated to drug resisitance to chemotherapy in NSCLC. The aim of this study is to investigate the expressions of P-gp, LRP, MRP and GST-π in samples from NSCLC patients before and after treatment with NACT, and their quantitative changes, so that to evaluate the influence of NACT on drug resistance to chemotherapy of NSCLC. Methods Total 92 specimens from 72 cases of NSCLC, including 52 samples of surgery excision from non-NACT-treated patients and 20 paired samples before and after NACT from the same patient, were studied. The expression of P-gp, LRP, MRP and GST-π was detected with tissue chip technique and immunohistochemistry. The quantitative analysis was carried out by computer image analysis system. Results In the samples before NACT, the positive rate of P-gp, LRP, MRP, GST-π expression was 66.67% (48/72), 72.22% (52/72), 81.94% (59/72), 83.33% (60/72), respectively. The expressive intensity of P-gp, LRP and GST-π was significantly stronger in adenocarcinoma than that in squamous cell carcinoma (P<0.05, P<0.001, P<0.001, respectively); there was no significant difference in the expression of MRP between adenocarcinoma and squamous cell carcinoma (P>0.05). In samples after treatment with NACT, the expression of P-gp, GST-π demonstrated by average optical density (AOD) and integral optical density (IOD) were significantly higher (P<0.05, P<0.001 respectively) than that in biopsied samples taken before NACT; The change in expression of P-gp, GST-π was also showed difference by different histopathological types, differentiations, ages, sizes, clinical stages as well as lymph node metastasis or not (P<0.05 or P<0.001). There was no significant difference between samples taken before and after NACT (P>0.05) in the expression of LRP and MRP demonstrated by both of AOD and IOD. Conclusion The results suggest that drug resistance in adenocarcinoma is primarily stronger than that in squamous cell carcinoma. NACT may enhance acquired drug resistance of NSCLC through inducing the expression of drug resistance protein. The results indicate that acquired drug resistance must be considered with the application of NACT to NSCLC patient in clinic, especially to patient in stage Ⅰ and Ⅱ. Since NACT may lead to the enhancement of acquired drug resistance in stage Ⅰ and Ⅱ, this may dwindle the therapeutic effect of chemotherapy after surgery. Comparative examination of drug resistance proteins before and after NACT, combining with comprehensive consideration of chemical regimens of NACT, should be recommended during chemotherapy of NSCLC for both before and after surgery.

Non-target Screening and Quantitation of Organic Chlorides in Oilfield Chemicals with Comprehensive Two Dimensional Gas Chromatography Coupled with Time of Flight Mass Spectrometry

Advanced analytical methodology based on comprehensive two-dimensional gas chromatography-time of flight mass spectrometry(GC×GC-TOFMS) is proposed for investigation of organic chlorides in different oilfield chemicals.The target screening was initially carried out on 8 suspected organic chlorides by evaluating the capability of the enhanced separation and reliable identification at a trace concentration. GC×GC-TOFMS allowed for the fast and automated analysis of organic chlorides at a level of 200 μg/L. This method was subsequently applied for non-target screening of organic chlorides in different oilfield chemicals at various locations across China. 22 organic chlorides were identified and verified by comparison with pure standards in the mixed sample. Finally, this method was used to determine the content of the organic chlorides in individual samples. The result showed that the organic chloride levels in 19 of the 39 tested oilfield chemicals were above the threshold limit of 1.0 mg/L.

Predicting quantitative structure-activity relationship of substituted 17α-acetoxyprogesterones by molecular hybridization electronegativity-distance vector

A set of novel structural descriptors (molecular hybridization electronegativity-distance vector, VMEDh) was put forward, and the quantitative structure–activity relationship (QSAR) of a series of 17α-Acetoxyprogesterones (APs) was investigated. Taking into account the effect of various hybridized orbits on atomic electronegativities, we developed the structure descriptors with amended electronegativities to build a QSAR model. The 10-parameter model based on VMEDh yields a correlation coefficient R=0.972 and standard deviation SD=0.262, which are more desirable than those of the previous molecular electonegativity-distance vector (MEDV-4) (R=0.969, SD=0.275). By stepwise multiple linear regression, several parameters are selected to construct optimal models. The 7-parameter model based on VMEDh has R=0.960 and SD=0.276; its correlation coefficient (RCV) and standard deviation (SDCV) for leave-one-out procedure crossvalidation are respectively RCV=0.890 and SDCV=0.445. The 6-parameter MEDV-4 model has R=0.946, SD=0.304, RCV=0.903 and SDCV=0.406. It is demonstrated that VMEDh has desirable estimation performance and good predictive capability for this series of chemical compounds.

IVIM-DWI多定量参数及血清lncRNA CASC9水平与肝细胞肝癌患者临床病理特征的相关性分析

目的:探讨体素内不相干运动-扩散加权成像(Intravoxel incoherent motion diffusion weighted imaging,IVIM-DWI)多定量参数及血清长链非编码RNA肿瘤易感候选者9(Long non-coding RNA tumor susceptibility candidate gene 9,lncRNA CASC9)水平与肝细胞肝癌(Hepatocellular carcinoma,HCC)患者临床病理特征的相关性。方法:选取2021年8月至2023年8月我院收治的89例HCC患者为研究对象,均行IVIM-DWI检查,并取HCC组织与癌旁组织。比较HCC组织、癌旁组织及不同临床病理特征HCC组织IVIM-DWI多定量参数:扩散系数(Diffusion coefficient,D)、假扩散系数(False diffusion coefficient,D^(*))、表观扩散系数(Apparent diffusion coefficient,ADC)、灌注分数(Perfusion fraction,PF)及血清lncRNA CASC9水平,分析多定量参数及血清lncRNA CASC9水平与临床病理特征之间的相关性。结果:HCC组织D、ADC水平低于癌旁组织,D^(*)、PF、lncRNA CASC9水平高于癌旁组织(P<0.05);HCC组织D、ADC水平比较:无门静脉癌栓>有门静脉癌栓,Ⅰ-Ⅱ期>Ⅲ-Ⅳ期,中高分化>低分化,无淋巴结转移>有淋巴结转移,D^(*)、PF、lncRNA CASC9水平比较:无门静脉癌栓<有门静脉癌栓,Ⅰ-Ⅱ期<Ⅲ-Ⅳ期,中高分化<低分化,无淋巴结转移<有淋巴结转移(P<0.05);HCC组织D、ADC水平与门静脉癌栓、TNM分期、分化程度、淋巴结转移均呈负相关,D^(*)、PF、lncRNA CASC9水平与之均呈正相关(P<0.05)。结论:IVIM-DWI多定量参数及血清lncRNA CASC9水平与HCC患者临床病理特征均具有一定相关性,联合应用可作用临床评估HCC病情的有效方式。

肥胖儿童non-HDL-C、remnant cholesterol与亚临床动脉粥样硬化的关系

目的:了解non-HDL-C和remnant cholesterol与肥胖儿童亚临床动脉粥样硬化(AS)的关系。方法:根据甘油三酯(TG)水平将65例肥胖儿童(肥胖组)分为I组(TG≥2.3 mmol/L)32例,II组(TG<2.3 mmol/L)33例,与肥胖组儿童性别年龄相匹配的正常体质量儿童30例为III组(对照组)。比较3组儿童血脂指标,对肥胖组各项血脂指标与血浆致动脉粥样硬化指数(AIP)进行相关性分析,肥胖患儿体质指数、血脂指标与颈动脉内径、内膜-中层厚度(c-IMT)、血流参数进行相关性分析。结果:I组、II组的TG、总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、non-HDL-C、remnant cholesterol、AIP均较对照组升高,高密度脂蛋白胆固醇(HDL-C)较对照组降低,且I组的remnant cholesterol、AIP均较II组升高。肥胖组儿童AIP与TG、non-HDL-C、remnant cholesterol呈正相关,与HDL-C呈负相关。37例行颈动脉超声检查的肥胖儿童的c-IMT较正常儿童的增厚。结论:non-HDL-C、remnant cholesterol在肥胖儿童亚临床AS中有重要作用,在肥胖儿童血脂异常的治疗中应关注non-HDL-C、remnant cholesterol的变化。

Shenqi Fuzheng injection combined with GP chemotherapy in the treatment of advanced non-small cell lung cancer： a meta-analysis

Objective： To evaluate the clinical efficacy of Shenqi Fuzheng injection combined with gemcitabine plus cisplatin（GP） in the treatment of advanced non-small cell lung cancer （NSCLC）. Methods： we performed a systematicsearch in the electronic databases such as Cochrane Library, Pubmed, Embase, Chinese Journal Full-text Database,Chinese Biomedical Literature Database, Chinese Science and Technology Periodical Full-text Database andWanfang Database up to 30 January 2017. Randomized controlled trials （RCT） of Shenqi Fuzheng Injectioncombined with GP chemotherapy in the treatment of advanced NSCLC were searched, and all the RCTs wereconducted on methodological quality assessment. Data extraction and data analysis were according to standards ofCochrane systematic review. Results： Eight trials were included including a total of 701 patients. Meta-analysisresults： Shenqi Fuzheng injection combined with GP chemotherapy could significantly improve the functionalstatus of patients with NSCLC （OR = 3.44, 95% CI [2.26, 5.25], P 〈 0.0001） and clinical treatment efficacy （OR =（OR = 0.31, 95%CI [0.20, 0.47], P 〈 0.0001. The rate of leukopenia （OR = .31, 95%CI [0.20,0.47], P 〈 0.0001）,thrombocytopenia （OR = 0.58, 95%CI [0.37, 0.91], P = 0.020）, hemoglobin decline （（OR = 0.31, 95%CI [0.16,0.59], P = 0.0004） and incidence of gastrointestinal reactions （OR = 0.58,P 〈 0.05） could be reduced. Conclusion：Shenqi Fuzheng injection combined with GP chemotherapy in the treatment of advanced NSCLC obtainedsignificantly clinical efficacy. The quality of the literature incorporated is low, the conclusion requires high-qualityresearch to further prove.

Relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma

Objective:To study the relevance of EGFR gene mutation with pathological features and prognosis in patients with non-small-cell lung carcinoma.Methods:A total of 297 patients from July 2009 to May 2013 were chosen as objects.EGFR gene mutation were detected with fluorescence quantitative PCR.Relevance of EGFR gene mutation with clinical and pathological features was analyzed,and the prognosis of EGFR- mutant-patients and that of EGFR- wide type-patients was compared.Results:In 297 patients.136(45.79%) showed EGFR gene mutation.EGFR gene mutation had no significant relevance with age.gender,smoking history,family history of cancer and clinical stage(P>0.05);there was significant relevance between EGFR gene mutation and blood type,pathologic types,differentiation and diameter of cancer(P<0.05).The difference between prognosis of EGFR- mutant-patients and that of EGFR- wide type-patients was statistical significance(P<0.05).Conclusions:EGFR gene mutation has significant relevance with pathological features,the prognosis of EGFRmutant-paticnts is better than that of EGFR- wide type-patients.

Analysis of Numerical Results in High Temperature Congealment and Chemistry Non-equilibrium Flow Field

Using the air plasma ignition technique, physicochemical process of burning can be accelerated; concentration limit ofretrofires both can be extended; reliability of retrofires and stability of burning can be improved. In this paper, using internalequivalent heat area in place of electric are that created Ohm heat, the flow fields of thermodynamic equilibrium chemistry con-gealment and chemistry non-equilibrium in the plasma generator were simulated. The influences of the inlet prerotation angleof air, the inlet total pressure of air and the airflow compression angle of spray nozzle on the temperature on the surface of elec-

Turbulent Flow Action of Pulp in Wet - Laid Non - Woven Processes

The paper deals with the fluid field of web forming in wet-laid non-woven production.The influence of the turbulent flow on blending fiber and occluded fluid produced in pulp flow has been discussed in theory and practice.The suitable use of the imported velocity of pulp is very important in producing wet-laid products of good quality.

Quantitative structure－activity study on the reductive dehalogenation potency of the halogenated aromatics

Ｑｕａｎｔｉｔａｔｉｖｅｓｔｒｕｃｔｕｒｅ－ａｃｔｉｖｉｔｙｓｔｕｄｙｏｎｔｈｅｒｅｄｕｃｔｉｖｅｄｅｈａｌｏｇｅｎａｔｉｏｎｐｏｔｅｎｃｙｏｆｔｈｅｈａｌｏｇｅｎａｔｅｄａｒｏｍａｔｉｃｓＨｕａｎｇＱｉｎｇｇｕｏ；ＷａｎｇＬｉａｎｓｈｅｎｇ；Ｈａｎ...

CYFRA 21-1 as an early predictor of first line chemotherapy response in advanced non small cell lung cancer

Objective： In an era of ever evolving, promising new therapies for advanced non small cell lung cancer （NSCLC）, early predictors of response to therapy, are needed. We evaluated early variations in CYFRA 21-1 serum levels of patients with advanced NSCLC receiving first line chemotherapy and correlated the results with objective tumor response. Methods： 29 consecutive, previously untreated, patients of advanced non small cell lung cancer, with measurable disease on CT scan were evaluated. All patients were treated with conventional systemic chemotherapy, although the choice of chemotherapy was left to the discretion of the treating physicians. Serum samples were obtained immediately before the start of 1st and 2nd cycles of chemotherapy. CYFRA 21-1 was measured with an electrochemiluminescense immunoassay on an automatic analyzer （Elecsys 2000; Roche Diagnostics）. Response was evaluated using Response evaluation criteria in solid tumors （RECIST） criteria. Results： 10 patients had partial response, 9 patients had stable disease and 9 had progressive disease. None of the patients had complete response. 21/29 （72%） patients had an elevated baseline value of CYFRA 21-1.62% patients （18/29） had a decrease in CYFRA 21-1 after 1 cycle of chemotherapy. The average reduction in the 2nd reading was irrespective of whether baseline value was normal or not. The average reduction was statistically significant （P = 0.002; 95% CI, from 0.8369 to 3.49464; t test）. 8 out of 10 （80%） patients with partial response had a reduction in their 2nd reading of. CYFRA （P = 0.019; 95% CI, from 0.81965 to 7.20035; t test） which was significant. We also observed that 6/9 （66%） patients whose disease remains stable also had a decrease in their subsequent reading （P = 0.0106; 95% CI, from -0.44942 to 3.82720; t test）, though it was not significant statistically. Although 5 out of 9 （55%） patients, who had an increase in their CYFRA 21-1 level, had progressive disease, but it was not statistically significant （P = 0.537; 95% CI, from -1.20021 to 2.13354; ttest）. 14 out of 19 （73%） who either had partial response or had stable disease, had a reduction in their 2nd value of CYFRA 21-1 and was significant statistically （P = 0.004; 95% CI, from 0.74792 to 3.50208; t test）. We also observed that except for 1 patient, all patients who had a decrease of 42% or more in their subsequent CYFRA 21-1 level, were those who had either responded to chemotherapy or had stable disease （P = 0.001）, which was statistically significant. Conclusion： We can conclude that monitoring of serum marker CYFRA 21-1, early dudng first-line chemotherapy may be a useful prognostic tool for evaluation of early tumor response in patients with advanced NSCLC.

MiR-16-5p plays an inhibitory role in human non-small cell lung cancer through Fermitin family member 2

Increasing evidence indicates that aberrant expressions of some microRNAs are associated with cancer progression.However,the roles and biological mechanisms of miRNA-16-5p in human non-small cell lung cancer(NSCLC)are not to be well studied.Here,we validated that the expression of miR-16-5p was decreased significantly in NSCLC samples and cell lines.The correlation between the clinicopathological features of NSCLC and the miR-16-5p expression showed that the expression of miR-16-5p in non-small cell lung cancer was linked with the advanced TNM stage,positive lymph node metastasis,with short overall survival(OS).Also,a negative correlation between miR-16-5p and Fermitin family member 2(FERMT2)was observed,implying there may be a potential link about their regulation.The hypothesis was further confirmed by in-silico analysis and dual-luciferase reporter assay.Moreover,we demonstrated that the transfections of miR-16-5p mimics could alter some biological characteristics of NSCLC cells remarkably accomplished by the expression variance of FERMT2 in vitro and in vivo assays.Summarily,this study demonstrated that miR-16-5p,as a tumor suppression factor in NSCLC by targeting FERMT2,could serve as one promising biomarker in the prediction for NSCLC patients.

金属构件缺陷的脉冲涡流近-远场复合定量检测

鉴于脉冲涡流检测和脉冲远场涡流检测在金属构件损伤检测中的优势,提出一种非铁磁性金属构件缺陷的脉冲涡流近-远场复合定量检测探头。通过数值仿真,在系统分析电磁场能流密度的基础上,研究脉冲涡流近-远场检测信号特性及其对构件腐蚀减薄缺陷的响应灵敏度,剖析检测信号特征与缺陷尺寸参数间的关联规律。同时,搭建试验平台,进一步探究基于脉冲涡流近-远场复合定量检测的非铁磁性金属构件腐蚀减薄缺陷定量检测方法。仿真及试验结果表明,所提集成磁场直接和间接耦合分量的新探头构型可同时对金属构件腐蚀减薄缺陷实施脉冲涡流检测和脉冲远场涡流检测,增强了缺陷定量信息的有效拾取。

基于Label-free技术的非小细胞肺癌蛋白质差异研究

目的 基于非小细胞肺癌(non-small-cell lung cancer,NSCLC)及与其配对的非癌性邻近组织(non-cancerous adjacent tissues,NATs)的蛋白质组学分析,寻找NSCLC诊断相关蛋白标志物。方法 应用非标记定量蛋白组学(LFP)技术,以NSCLC患者配对的NATs为对照,对5例NSCLC患者进行癌组织蛋白质组学分析。以差异倍数>1.5(上调)或<0.67(下调)且P<0.05为标准筛选差异蛋白。应用String网站和R语言对差异蛋白进行基因本体论(gene ontology,GO)分析、京都基因和基因组百科全书(Kyoto Encyclopedia of Genes and Genomes,KEGG)分析,为进一步研究提供良好基础。结果 本研究发现差异蛋白共644个,其中339个蛋白表达上调,305个蛋白表达下调。PCA结果显示,差异蛋白可明显区分NSCLC与NATs。GO分析结果表明,差异蛋白大多以细胞外泌体的形式存在且主要富集于调节胞外分泌、胞外分泌、骨髓细胞激活参与免疫反应等的生物学过程以及钙粘着蛋白绑定、细胞外基质绑定等的分子功能。KEGG分析结果显示,差异蛋白主要富集在抗坏血酸和醛酸代谢、组氨酸代谢、蛋白质消化吸收、丙酮酸代谢等通路(P<0.05)。结论 NSCLC与NATs存在明显差异,可为发现NSCLC新型标志物提供线索。

Quantitative Security Evaluation for Software System from Vulnerability Database

This paper proposes a quantitative security evaluation for software system from the vulnerability data consisting of discovery date, solution date and exploit publish date based on a stochastic model. More precisely, our model considers a vulnerability life-cycle model and represents the vulnerability discovery process as a non-homogeneous Poisson process. In a numerical example, we show the quantitative measures for contents management system of an open source project.

血清lncRNA T342620联合AFP对肝癌的诊断价值

目的探究肝癌患者血清长链非编码RNA(lncRNA)T342620的表达水平,及其单独或联合甲胎蛋白(AFP)诊断肝癌的临床应用价值。方法采用病例对照研究,收集2021年4月至2023年5月在中国人民解放军南部战区总医院治疗的69例原发性肝癌患者(肝癌组)、32例乙型肝炎患者(乙肝组)、20例肝硬化患者(肝硬化组)、30例原发性肝癌经导管肝动脉化疗栓塞术(TACE)术后患者(肝癌术后组)和同期进行体检的50例健康者(健康体检组)的血清,提取血清总RNA,采用实时荧光定量PCR技术,检测血清中lncRNA T342620的相对表达量;结合患者临床诊疗资料,分析其表达水平与病理特征和血清学相关指标的相关性;运用受试者工作特征(ROC)曲线分析lncRNA T342620单独及联合AFP对肝癌诊断的特异度和灵敏度。根据ROC曲线下面积(AUC)判断诊断效能,评估其在肝癌诊断中的应用价值。各组间比较采用χ^(2)检验,相关性分析采用Spearman法。结果lncRNA T342620在肝癌组和肝癌术后组血清表达水平较健康体检组、乙肝组、肝硬化组高,差异均具有统计学意义(P<0.001);临床病理和血清学相关指标分析显示:肿瘤越大,血清lncRNAT342620表达水平越高,肝癌组血清lncRNA T342620表达水平与白蛋白(ALB)和白球比(A/G)呈负相关(P<0.05),与α-L-岩藻糖苷酶(AFU)和HBV-DNA呈正相关(P<0.05),肝癌术后组患者血清lncRNA T342620表达水平与总胆汁酸(TBA)呈正相关(P<0.05);ROC曲线分析显示:血清lncRNA T342620用于区别肝癌患者与健康者、乙肝和肝硬化患者时,其灵敏度和特异度分别为55.1%和94.1%,具有较好的诊断价值;和AFP联合检测时,灵敏度和特异度分别为91.3%和91.2%,其灵敏度高于各单项指标诊断的灵敏度,且联合检测诊断效能最高,AUC为0.954,与AFP和lncRNA-T342620单独检测的AUC(0.906、0.758)比较,差异有统计学意义(P<0.05)。结论血清lncRNA T342620有可能成为肝癌辅助诊断的新型血清分子标志物。

激光声表面波技术在材料加工表面损伤检测中的应用

激光声表面波技术是一种新兴的无损检测方法,在材料加工表面损伤评估中展现出独特优势。本文重点探讨了该技术在表面裂纹、粗糙度和热损伤定量表征方面的应用。通过激光激发表面波并分析其传播特性,实现了高灵敏度、强定量化能力的损伤检测。优化激励-接收方案和信号处理算法,可进一步提升检测性能。实验研究表明,表面波的时频域特征参数与损伤量纲间存在确定性关联,为工程应用奠定了基础。

基于自发漏磁效应的钢丝束多点断丝损伤检测研究

斜拉索的完整性对斜拉桥的服役安全至关重要。针对斜拉索突出的断丝损伤问题,本工作利用37根钢丝排列组成平行钢丝束模拟拉索试件,设置了不同工况模拟拉索的断丝状态,分析漏磁信号曲线变化特征并构建了特征指标(B_(sd))以定量评估拉索的断丝损伤程度。结果表明:不同断丝率下磁感应强度法向分量(B_(z))曲线两极值间水平间距与断丝宽度呈良好的线性正相关,且极值间距的变化对断丝率的影响不敏感;磁感应强度切向分量(B_(x))、B_(z)值在相同断丝宽度、不同断丝率条件下的增量比在相同断丝率、不同断丝宽度条件下的增量大,说明漏磁信号受断丝率的影响更大;采用二次多项式可以较好地拟合断丝宽度、断丝率与特征指标之间的相关性,不同影响因素与指标的拟合优度均大于0.95;随断丝宽度和断丝率的增加,拟合曲线与曲面的斜率都逐渐减小;通过特征指标在不同影响因素下的增量分析,验证了断丝率对漏磁信号的影响大于断丝宽度。